121 related articles for article (PubMed ID: 10708268)
1. Platelet [3H]paroxetine binding in patients with OCD-related disorders.
Marazziti D; Dell'Osso L; Presta S; Pfanner C; Rossi A; Masala I; Baroni S; Giannaccini G; Lucacchini A; Cassano GB
Psychiatry Res; 1999 Dec; 89(3):223-8. PubMed ID: 10708268
[TBL] [Abstract][Full Text] [Related]
2. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
[TBL] [Abstract][Full Text] [Related]
3. Decreased lymphocyte 3H-paroxetine binding in obsessive-compulsive disorder.
Marazziti D; Baroni S; Masala I; Giannaccini G; Mungai F; Di Nasso E; Cassano GB
Neuropsychobiology; 2003; 47(3):128-30. PubMed ID: 12759554
[TBL] [Abstract][Full Text] [Related]
4. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification.
D'Hondt P; Maes M; Leysen JE; Gommeren W; Scharpé S; Cosyns P
J Affect Disord; 1994 Sep; 32(1):27-35. PubMed ID: 7798464
[TBL] [Abstract][Full Text] [Related]
5. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
Sallee FR; Richman H; Beach K; Sethuraman G; Nesbitt L
J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1647-56. PubMed ID: 8973072
[TBL] [Abstract][Full Text] [Related]
6. Increased density of the platelet serotonin transporter in autism.
Marazziti D; Muratori F; Cesari A; Masala I; Baroni S; Giannaccini G; Dell'Osso L; Cosenza A; Pfanner P; Cassano GB
Pharmacopsychiatry; 2000 Sep; 33(5):165-8. PubMed ID: 11071017
[TBL] [Abstract][Full Text] [Related]
7. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
[TBL] [Abstract][Full Text] [Related]
8. Platelet paroxetine binding in post-traumatic stress disorder.
Maguire K; Norman T; Burrows G; Hopwood M; Morris P
Psychiatry Res; 1998 Jan; 77(1):1-7. PubMed ID: 10710169
[TBL] [Abstract][Full Text] [Related]
9. [3H]paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers.
Stein MB; Delaney SM; Chartier MJ; Kroft CD; Hazen AL
Biol Psychiatry; 1995 Feb; 37(4):224-8. PubMed ID: 7711158
[TBL] [Abstract][Full Text] [Related]
10. Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine.
Marazziti D; Pfanner C; Palego L; Gemignani A; Milanfranchi A; Ravagli S; Lensi P; Presta S; Cassano GB
Pharmacopsychiatry; 1997 Nov; 30(6):245-9. PubMed ID: 9442546
[TBL] [Abstract][Full Text] [Related]
11. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
[TBL] [Abstract][Full Text] [Related]
12. No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients.
Marazziti D; Conti L; Pfanner C; Presta S; Rossi A; Gemignani A; Dell'Osso L; Cassano GB
Neuropsychobiology; 2001; 43(3):117-22. PubMed ID: 11287787
[TBL] [Abstract][Full Text] [Related]
13. Decreased platelet [3H]paroxetine binding sites in suicide attempters.
Marazziti D; Dell'Osso L; Rossi A; Masala I; Baroni S; Armani A; Giannaccini G; Di Nasso E; Lucacchini A; Cassano GB
Psychiatry Res; 2001 Sep; 103(2-3):125-31. PubMed ID: 11549401
[TBL] [Abstract][Full Text] [Related]
14. Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder.
Weizman A; Mandel A; Barber Y; Weitz R; Cohen A; Mester R; Rehavi M
Biol Psychiatry; 1992 Apr; 31(7):705-11. PubMed ID: 1318082
[TBL] [Abstract][Full Text] [Related]
15. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet.
Coccaro EF; Kavoussi RJ; Sheline YI; Lish JD; Csernansky JG
Arch Gen Psychiatry; 1996 Jun; 53(6):531-6. PubMed ID: 8639036
[TBL] [Abstract][Full Text] [Related]
16. Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD.
Marazziti D; Masala I; Rossi A; Hollander E; Presta S; Giannaccini G; Mazzoni MR; Dell'Osso L; Lucacchini A; Cassano GB
Neuropsychobiology; 2000; 41(4):171-7. PubMed ID: 10828725
[TBL] [Abstract][Full Text] [Related]
17. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
Kim SW; Dysken MW; Pandey GN; Davis JM
Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of an aryl-azidoparoxetine. A novel photo-affinity probe for serotonin-transporter.
Chudzik J; McCarthy D; Bakish D; Ravindran A; Hrdina PD
Biochem Pharmacol; 1995 Oct; 50(8):1211-5. PubMed ID: 7488236
[TBL] [Abstract][Full Text] [Related]
19. Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients.
Marazziti D; Dell'Osso B; Baroni S; Betti L; Catena M; Giannaccini G; Lucacchini A; Cassano GB
Pharmacopsychiatry; 2006 Jan; 39(1):35-8. PubMed ID: 16453253
[TBL] [Abstract][Full Text] [Related]
20. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.
Owens MJ; Nemeroff CB
Clin Chem; 1994 Feb; 40(2):288-95. PubMed ID: 7508830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
